Frélii, Inc. Stock

FRLI

US3570511010

Advanced Medical Equipment & Technology

Real-time OTC Markets Other stock markets 01:31:24 16/09/23 am AEST			5-day change	1st Jan Change
0.000100 ^USD	-.--%		-.--%	-

17/12/20	Frélii, Inc. cancelled the acquisition of 25% shares of Genecor AI Inc. from Helix Investment Partners LLC.	CI
09/01/20	Frélii, Inc. announced that it has received $0.203 million in funding	CI

Frelii, Inc. provides Web-based nutrition and fitness programs based on usersâ€™ genetic data. The Company provides users personalized, deoxyribonucleic acid (DNA)-based diet and nutrition plans and identifies usersâ€™ health risks. Users can upload their raw genetic data by logging into their 23andMe profile and the Companyâ€™s site uploads that data for use by its artificial intelligence (AI)-based algorithm. Its products include KDIR, EZV-200, BLDB Tonic, Keotone-CoCoa and CTV. The Company provides tools, which includes personalized cookbook, meal planning, shopping lists, supplement packages and video workouts. It provides Navii, which is computer learning-based algorithm generates insight about individual genetic health risks, and assists health providers to identify and treat various health concerns. Its wellness plans feature nutrition and fitness plans, supplement recommendations, downloadable menus, recipes, and shopping lists, and virtual personal training.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Rankings

Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

Stock Market
Stocks
FRLI Stock

As early as today, start finding the best investment opportunities!

Market Cap	11.76M 10.18M 9.52M 8.7M 16.39M 1.12B 16.65M 112M 43.8M 561M 44.17M 43.21M 1.87B	P/E 2017	21.4x	P/E 2018	-12.5x
Enterprise Value	11.7M 10.13M 9.47M 8.66M 16.31M 1.12B 16.57M 111M 43.58M 558M 43.95M 42.99M 1.86B	EV / Sales 2017	-	EV / Sales 2018	2,167,635,443x
Free-Float	100%	Yield 2017 *	-	Yield 2018	-

17/12/20	Frélii, Inc. cancelled the acquisition of 25% shares of Genecor AI Inc. from Helix Investment Partners LLC.	CI
09/01/20	Frélii, Inc. announced that it has received $0.203 million in funding	CI
23/12/19	Frélii, Inc. entered into share purchase agreement to acquire 25% shares of Genecor AI Inc. for $0.94 million from Helix Investment Partners LLC.	CI
15/11/19	Frélii, Inc. announced that it has received $0.154 million in funding	CI
15/11/19	Frélii, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019	CI
15/08/19	Frélii, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019	CI
16/07/19	Frelii, Inc. Announces Resignation of Leslie Norris as Chief Operating Officer; Opens Its First Wholly Owned Subsidiary, Frelii Canada Inc. in Mississauga, Ontario, Canada	CI
10/06/19	Frélii, Inc. Inks Agreement with Orn Health Inc. to Support Healthcare Franchisee Partners Incorporating Pharmacogentics Into Patient Treatment	CI
23/05/19	Frelii Inc. Announces Executive Changes	CI
20/05/19	Frélii, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019	CI
01/05/19	Frélii, Inc. Signs Contract and Licensing Agreement with Optivida Health	CI
16/04/19	Frélii, Inc. Reports Earnings Results for the Full Year Ended December 31, 2018	CI
13/04/19	Frélii, Inc. Announces Address Change	CI

1 month	+9,900.00%
3 months	+9,900.00%
6 months	+9,900.00%

1 month	0		0
Current year	0		0
1 year	0		0
3 years	0		0
5 years	0		0.04
10 years	0		10

Manager	Title	Age	Since
Ian Jenkins CEO	Chief Executive Officer	42	05/04/2017
Sandeep Uppal ADM	Chief Administrative Officer	-	22/05/2019
Jayson Uffens CTO	Chief Tech/Sci/R&D Officer	51	15/05/2018

Frélii, Inc. Stock

Stocks

FRLI

US3570511010

Advanced Medical Equipment & Technology

Valuation: Frélii, Inc.

Latest news : Frélii, Inc.

Quotes and Performance

Course Extremes

Managers and Directors: Frélii, Inc.

Medical Software & Technology Services

Financials

Company Profile

Director	Title	Age	Since
Ian Jenkins BRD	Director/Board Member	42	05/04/2017
Tarek Mango BRD	Director/Board Member	55	01/01/2018
Hans Jenkins BRD	Director/Board Member	49	27/03/2018

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
FRÉLII, INC.	-.--%	-.--%	+9,900.00%	-.--%	5.9K
VEEVA SYSTEMS INC.	+1.72%	+14.17%	-14.98%	+22.23%	37.44B
PRO MEDICUS LIMITED	+0.30%	+8.88%	-42.75%	+149.03%	12.99B
SECTRA AB	+1.35%	+1.12%	-22.84%	+65.55%	5.44B
HEARTFLOW, INC.	+2.62%	+11.79%	-0.25%	-	2.49B
GENERATE BIOMEDICINES, INC.	+2.26%	+1.26%	-	-	1.84B
OMNICELL, INC.	+0.75%	-1.53%	+20.26%	-42.25%	1.68B
XUNFEI HEALTHCARE TECHNOLOGY CO., LTD.	+4.15%	+1.47%	-32.68%	-	1.02B
ARBUTUS BIOPHARMA CORPORATION	-1.62%	+5.39%	+37.16%	+123.06%	915M
B-SOFT CO.,LTD.	+1.65%	+3.36%	-32.29%	-46.83%	833M
Average	+1.51%	+4.64%	+1,090.18%	+38.68%	6.46B
Weighted average by Cap.	+1.65%	+10.09%	-19.63%	+52.74%

	2017	2018
Net sales	-	0.04 0.03 0.03 0.03 0.05 3.43 0.05 0.34 0.13 1.72 0.13 0.13 5.71
Net income	595K 516K 482K 440K 830K 56.79M 843K 5.65M 2.22M 28.41M 2.24M 2.19M 94.63M	-5.55M -4.8M -4.49M -4.1M -7.73M -529M -7.86M -52.66M -20.66M -265M -20.84M -20.38M -882M
Net Debt	37.06K 32.09K 29.99K 27.41K 51.65K 3.53M 52.46K 352K 138K 1.77M 139K 136K 5.89M	-58.56K -50.69K -47.38K -43.31K -81.61K -5.58M -82.88K -556K -218K -2.79M -220K -215K -9.31M